Cerebrospinal Fluid Total and Phosphorylated Tau Protein in Behavioral Variant Frontotemporal Dementia, Progressive Supranuclear Palsy, Corticobasal Syndrome and Non-Fluent Agrammatic Primary Progressive Aphasia: A Systematic Review and Meta-Analysis
View abstract on PubMed
Summary
This summary is machine-generated.Cerebrospinal fluid (CSF) phosphorylated tau (p-tau) may be decreased in tauopathies, while total tau (t-tau) is increased in frontotemporal lobar degeneration (FTLD) subtypes. Alzheimer's disease (AD) admixture and study heterogeneity complicate FTLD research.
Area Of Science
- Neuroscience
- Biochemistry
- Clinical Neurology
Background
- Frontotemporal lobar degeneration (FTLD) encompasses diverse tauopathies like Pick's disease, progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD).
- These conditions manifest in distinct syndromes: behavioral variant frontotemporal dementia (bvFTD), Richardson syndrome (RS), corticobasal syndrome (CBS), and non-fluent agrammatic primary progressive aphasia (nfa-PPA).
Purpose Of The Study
- To evaluate the diagnostic utility of cerebrospinal fluid (CSF) total tau (t-tau) and phosphorylated tau (p-tau) in distinguishing FTLD subtypes and tauopathies.
- To analyze CSF t-tau and p-tau levels in patients with bvFTD, RS, CBS, nfa-PPA, and pathologically confirmed tauopathies compared to controls.
Main Methods
- A systematic review and meta-analysis of studies with over 10 subjects per group.
- Inclusion of studies with available CSF t-tau or p-tau mean and standard deviation data.
- Quantification of effect sizes using Cohen's d.
Main Results
- Patients with PSP and other tauopathies showed decreased CSF p-tau levels relative to controls.
- Cohorts with CBS, bvFTD, and nfa-PPA demonstrated elevated CSF t-tau levels compared to control groups.
Conclusions
- A potential intrinsic decrease in CSF p-tau may characterize tauopathies.
- Confounding factors in FTLD research include the presence of Alzheimer's disease (AD) patients in FTD cohorts and significant heterogeneity in studies of rare diseases.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
The cephalic phase is a conditioned or learned response to familiar foods. Our appetite or desire for a particular food modifies the preparatory responses directed by the brain. Individuals may produce more saliva and stomach...
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....

